Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective ...

Epic Systems has introduced a new initiative called Launchpad. This initiative, according to a May 22 LinkedIn post from Epic, is designed to help healthcare organizations implement generative ...

Clinical trials are a crucial step in medical research, and without adequate numbers of participants, treatments can be ...

Checkmarx, the leader in autonomous application security for the enterprise, will demonstrate its agentic AI vision and discuss its implications for closing the speed gap between security and software ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

If you’re anything like me, what finally made you stop rolling your eyes at the term “artificial intelligence” was OpenAI’s ...

AI is racing into healthcare, but most organizations are still stuck at the starting line.  | Despite all the AI hype, most ...

Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug ...

Europe's path to AI competitiveness lies in cutting red tape that hinders startups, not in removing AI safeguards.

A new generation of checkpoint inhibitors is emerging, with some showing more promise than others. From recent TIGIT failures ...

Following after is P-500, a selective, brain-penetrant PRMT5 inhibitor for advanced solid tumours, including high-grade ...